Catherine (cate) M. Lockhart MS, PharmD, PhD

Cate Lockhart is an Executive Director at Biologics and Biosimilars Collective Intelligence Consortium. She understands the theory behind health economics and outcomes research, as well as the practical execution of pharmacoeconomic and clinical analyses, including the development of pharmacoeconomic models and analysis of complex clinical and economic data.

She has done extensive research, medical writing, and consulting in multiple disease states and therapeutic areas, producing clinical and economic reviews, pharmacoeconomic models, and AMCP dossiers to support formulary decisions and value assessments of pharmaceutical products across a variety of therapeutic areas. Cate has a unique breadth of formal training and practical experience and knowledge in basic science, managed care pharmacy, clinical analyses, and quantitative sciences including outcomes research, health economics, and epidemiology.

Cate has three undergraduate degrees: B.S. in Electrical Engineering, B.S. in Visual Communications, and B.F.A. in Theatre Arts. She completed three advanced degrees from the University of Washington in Seattle: the PharmD, the M.S. in Health Economics and Outcomes Research, and the Ph.D. in Pharmaceutical Sciences. She has a U.S. Patent, “Calibration Method and System for PET Scanners.”